Vaccination against Human Papilloma Virus (HPV) is widely accepted as a preventive measure against cervical cancer. Bogani and colleague researchers from Italy reported on a study of women who received the HPV vaccine but developed premalignant disease of the cervix. Their analysis considers how much of the disease could have been prevented if other vaccine types were used. Studies like this will help us to identify the most effective vaccine to use for cervical cancer prevention.
This article is open access and free to view online!